Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management
Tóm tắt
Từ khóa
Tài liệu tham khảo
Agarwal, 2003, Erectile dysfunction in diabetes mellitus: Novel treatments, Interantion Journal of Diabetes Development Countries, 23, 94
Arie, 2003, Prevalence and risk factors for erectile dysfunction in men with diabetes, hypertension, or both diseases: A community survey among 1,412 Israeli men, Clinical Cardiology, 26, 25, 10.1002/clc.4960260106
Atul, 2008, Erectile dysfunction in diabetic males: Plausible mechanisms and management strategies, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2, 81, 10.1016/j.dsx.2007.11.005
Ayta, 1999, The likely worldwide increase in erectile dysfunction between 1995 and 2005 and some possible policy consequences, BJU International, 84, 50, 10.1046/j.1464-410x.1999.00142.x
Bacon, 2002, Association of type and duration of diabetes with erectile dysfunction in a large cohort of men, Diabetes Care, 25, 1458, 10.2337/diacare.25.8.1458
Beavo, 1995, Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms, Physiological Review, 75, 725, 10.1152/physrev.1995.75.4.725
Bivalacqua, 2004, RhoA/Rho kinase suppresses endothelial nitric oxide synthase in the penis: A mechanism for diabetes associated erectile dysfunction, Proceeding of the National Academy of Sciences of the United States of America, 101, 9121, 10.1073/pnas.0400520101
Broderick, 2002, Evaluation and nonsurgical management of erectile dysfunction and priapism, 1619
Burke, 2007, Diabetes and sexual dysfunction: Results from the Olmsted county study of urinary symptoms and health status among men, Journal of Urology, 177, 1438, 10.1016/j.juro.2006.11.059
Burns, 1998, Medical management of erectile dysfunction, Postgrad Med J, 74, 336, 10.1136/pgmj.74.872.336
Cartledge, 2001, Advanced glycation end- products are responsible for the impairment of corpus cavernosal smooth muscle relaxation seen in diabetes, BJU International, 87, 402, 10.1046/j.1464-410x.2001.00067.x
Cellek, 1999, Selective nitrergic neurodegeneration in diabetes mellitus — A nitric oxide dependent phenomenon, British Journal of Pharmacology, 128, 1804, 10.1038/sj.bjp.0702981
Chang, 2004, Downregulation of cGMP-dependent protein kinase-1 activity in the corpus cavernosum smooth muscle of diabetic rabbits, American Journal of Physiology Regulatory Integrative and Comparative Physiology, 287, R950, 10.1152/ajpregu.00639.2003
Christ, 1995, Differential sensitivity of corporal smooth muscle from diabetic and nondiabetic patients to relaxation by potassium channel modulators, Journal of Andrology, 16, 55
Christian, 2005, Strategies in the oral pharmacotherapy of male erectile dysfunction viewed from bench and bedside (Part II), Journal of Men's Health, 2, 325
Clozel, 1992, The endothelin ETB receptor mediates both vasodilation and vasoconstriction in vivo, Biochemical and Biophysical Research Communications, 186, 867, 10.1016/0006-291X(92)90826-7
Costabile, 2003, Optimizing treatment for diabetes mellitus induced erectile dysfunction, Journal of Urology, 170, S35, 10.1097/01.ju.0000077448.31995.99
Fedele, 2000, Erectile dysfunction in type 1 and type 2 diabetics in Italy, International Journal of Epidemiology, 29, 524, 10.1093/ije/29.3.524
Gerald, 2002, Oral agents: First-line therapy for erectile dysfunction, European Urology Supplements, 1, 12, 10.1016/S1569-9056(02)00113-6
Giuseppe, 2006, Pharmacology of erectile dysfunction in man, Pharmacology & Therapeutics, 111, 400, 10.1016/j.pharmthera.2005.10.011
Goldstein, 2001, Vasomax for the treatment of male erectile dysfunction, World Journal of Urology, 19, 51, 10.1007/s003450000178
Guay, 2007, The relationship between testosterone levels, the metabolic syndrome (by two criteria), and insulin resistance in a population of men with organic erectile dysfunction, Journal of Sexual Medicine., 4, 1046, 10.1111/j.1743-6109.2007.00530.x
Hartman, 1998, The efficacy of psychosexual therapy for erectile dysfunction: A critical review of outcome studies, International Journal of Impotence Research, 10, S23
Haslett, 2002, 641
Hatzimouratidis, 2005, A comparative review of the options for treatment of erectile dysfunction: Which treatment for which patient?, Drugs, 65, 1621, 10.2165/00003495-200565120-00003
Heaton, J. P., Adams, M. A., & Morales, A. (1996). Apomorphine SL effective in the treatment of non organic erectile dysfunction: Results of a multicenter trial. International Journal of Imporant Research, 8, A64, 115.
Heaton, 2001, Key issues from the clinical trials of apomorphine SL, World Journal of Urology, 19, 25, 10.1007/s003450000174
Hedlund, 2000, Erectile dysfunction in cyclic GMP-dependent kinase I-deficient mice, Proceeding of the National Academy of Sciences of the United States of America, 97, 2349, 10.1073/pnas.030419997
Hilary, 1998, Global burden of diabetes, 1995-2025. Prevalence, numerical estimates, and projections, Diabetes Care, 21, 1414, 10.2337/diacare.21.9.1414
Johannes, 2000, Incidence of erectile dysfunction in men 40 to 69 years old: Longitudinal results from the Massachusetts male aging study, Journal of Urology, 163, 460, 10.1016/S0022-5347(05)67900-1
Kew-Kim, 2006, Pharmacotherapy of erectile dysfunction: Current standards, Indian Journal of Urology, 22, 235, 10.4103/0970-1591.27631
Klein, 1996, Prevalence of self-reported erectile dysfunction in people with long-term IDDM, Diabetes Care, 19, 135, 10.2337/diacare.19.2.135
Konstantinos, 2009, Erectile dysfunction and diabetes mellitus, Insulin, 4, 114, 10.1016/S1557-0843(09)80020-1
Kotera, 2003, cGMP-dependent protein kinase protects cGMP from hydrolysis by phosphodiesterase-5, Biochemical Journal, 372, 419, 10.1042/bj20030107
Kumar, 2004, 641
Kwan, 2005, Sexual dysfunction and chronic pain: The role of psychological variables and impact on quality of life, European Journal of Pain, 9, 643, 10.1016/j.ejpain.2004.12.008
Laumann, 1999, Sexual dysfunction in the United States: Prevalence and predictors, JAMA, 281, 537, 10.1001/jama.281.6.537
Lewis, 1996, Epidemiology of erectile dysfunction, Urologic Clinics of North America, 28, 209, 10.1016/S0094-0143(05)70132-4
Mills, 2001, Endothelin-1-induced vasoconstriction is inhibited during erection in rats, American Journal of Physiology Regulatory Integrative and Comparative Physiology, 281, R476, 10.1152/ajpregu.2001.281.2.R476
Ming, 2002, Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells, Molecular and Cellular Biology, 22, 8467, 10.1128/MCB.22.24.8467-8477.2002
Moemen, 2004, Clinical and sonographic assessment of the side effects of intracavernous injection of vasoactive substances, International Journal of Imporant Research, 16, 143, 10.1038/sj.ijir.3901194
Moncada, 2004, Current role of penile implants for erectile dysfunction, Current Opinion in Urology, 14, 375, 10.1097/00042307-200411000-00014
Montague, 2001, Penile prosthesis infections, International Journal of Imporant Research, 13, 326, 10.1038/sj.ijir.3900768
Moore, 2006, Pathophysiology and treatment of diabetic erectile dysfunction, Asian Journal of Andrology, 8, 675, 10.1111/j.1745-7262.2006.00223.x
Muammer, 2006, Gene therapy for erectile dysfunction: Fact or fiction?, European Urology, 50, 1208, 10.1016/j.eururo.2006.08.007
Mulhall, 2001, An open-label, uncontrolled dose-optimization study of sublingual apomorphine in erectile dysfunction, Clinical Therapeutic, 23, 1260, 10.1016/S0149-2918(01)80105-3
Nraga, 1996, Chlorpromazine a good substitute drug for phentolamine: A follow up of 174 patients, International Journal of Imporant Research, 8, 113
Padma-Nathan, 1997, Treatment of men with erectile dysfunction with transurethral alprostadil, New England Journal of Medicine, 336, 1, 10.1056/NEJM199701023360101
Park, 2002, Role of rho-kinase activity in angiotensin II-induced contraction of rabbit clitoral cavernosum smooth muscle, International Journal of Imporant Research, 14, 472, 10.1038/sj.ijir.3900911
Porst, 2000, Current perspectives on intracavernosal pharmacotherapy for erectile dysfunction, International Journal of Imporant Research, 12, S91, 10.1038/sj.ijir.3900585
Price, 1991, The management of impotence in diabetic men by vacuum tumescence therapy, Diabetic Medicine, 8, 964, 10.1111/j.1464-5491.1991.tb01538.x
Rees, 2002, Human and rabbit cavernosal smooth muscle cells express Rho-kinase, International Journal of Imporant Research, 14, 1, 10.1038/sj.ijir.3900814
Rosen, 2000, The female sexual function index (FSFI): A multidimensional self-report instrument for the assessment of female sexual function, Journal of Sex & Marital Therapy, 26, 191, 10.1080/009262300278597
Savoca, 2002, Intracavernosal injection therapy and surgical therapy in diabetic patients with erectile dysfunction, Diabetes Nutrition & Metabolism, 15, 53
Sidi, 1990, Patient acceptance of and satisfaction with an external negative pressure device for impotence, Journal of Urology, 144, 1154, 10.1016/S0022-5347(17)39679-9
Sullivan, 1997, Alterations in endothelin B receptor sites in cavernosal tissue of diabetic rabbits: Potential relevance to the pathogenesis of erectile dysfunction, Journal of Urology, 158, 1966, 10.1016/S0022-5347(01)64195-8
Takahashi, 1990, Elevated plasma endothelin in patients with diabetes mellitus, Diabetologia, 33, 306, 10.1007/BF00403325
Vernet, 1995, Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (Type II) rats with erectile dysfunction, Endocrinology, 136, 5709, 10.1210/en.136.12.5709
Wallis, 1999, Tissue distribution of phosphodiesterase families and the effects of sildenafil on tissue cyclic nucleotides, platelet function, and the contractile responses of trabeculae carnae and aortic rings in vitro, American Journal of Cardiology, 83, 3C, 10.1016/S0002-9149(99)00042-9
Wang, 2002, RhoAmediated Ca2+ sensitization in erectile function, Journal of Biological Chemistry, 277, 30614, 10.1074/jbc.M204262200
Wild, 2004, Global prevalence of diabetes: Estimates for 2000 and projections for 2030, Diabetes Care, 27, 1047, 10.2337/diacare.27.5.1047